Home › Asset managers › Compare 2025-2026 › Invesco vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Invesco 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 53,305 | 38,593 | 3,447 | 11,265 | 91.8% | 85.4% |
| Board proposals | 45,557 | 32,017 | 3,137 | 10,403 | 91.1% | 84.6% |
| E&S shareholder proposals | 173 | 0 | 0 | 173 | n/a | 40.9% |
| Other items | 7,575 | 6,576 | 310 | 689 | 95.5% | 91.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
10,403 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Invesco | Brighthouse |
|---|---|---|---|---|---|---|
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Eric P. Palmer Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: James H. Hinton Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Jorge A. Caballero Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Mark G. Foletta Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Teri G. Fontenot Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
Split 2 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Advisory vote to approve compensation of named executive officers Say-on-Pay |
Board | For | Split 34 FOR, 11 AGAINST |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as independent public accountants Audit-related |
Board | For | FOR 38 funds |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| AMPRIUS TECHNOLOGIES, INC. | June 11, 2026 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | Not determined | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 5 funds |
Split 2 FOR, 2 AGAINST |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 45 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 33 funds |
Split 7 FOR, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 33 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANDRITZ AG | March 26, 2026 | Elect Wolfgang Leitner as Supervisory Board Member Director Elections |
Board | For | Split 2 FOR, 2 AGAINST |
AGAINST 1 fund |
| ANGLO AMERICAN PLC | December 9, 2025 | Amend Long-Term Incentive Plan Compensation |
Board | For | Split 3 FOR, 8 AGAINST |
AGAINST 3 funds |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF HELOISA SICUPIRA AS DIRECTOR AND ELECT MIGUEL PATRICIO AS DIRECTOR Director Elections |
Board | For | Split 5 FOR, 10 AGAINST |
AGAINST 3 funds |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF MARTIN J. BARRINGTON AS RESTRICTED SHARE DIRECTOR AND ELECT WILLIAM F. GIFFORD, JR. AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF NITIN NOHRIA AS DIRECTOR AND ELECT FABRIZIO FREDA AS DIRECTOR Director Elections |
Board | For | Split 5 FOR, 10 AGAINST |
AGAINST 3 funds |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF SALVATORE MANCUSO AS RESTRICTED SHARE DIRECTOR AND ELECT JENNIFER HUNTER AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | FOR 15 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | AUTHORIZE REPURCHASE OF UP TO 20 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | FOR 15 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | REELECT ALEJANDRO SANTO DOMINGO AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | Split 11 FOR, 4 AGAINST |
Split 1 FOR, 2 AGAINST |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 12 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Antonio R. Pera Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Jeanne A. Thoma Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Matthew J. Leonard, R.Ph. Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Muthusamy Shanmugam Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Nikhil Lalwani Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Renee P. Tannenbaum, Pharm.D. Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Thomas J. Haughey Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 17 funds |
Split 3 FOR, 2 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 3 FOR, 2 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 2 AGAINST |
Split 3 FOR, 3 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Midstream Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 14 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
Split 3 FOR, 1 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Resources Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 11 funds |
Split 3 FOR, 1 ABSTAIN |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 33 funds |
Split 3 FOR, 5 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board or the Audit Committee of the Board to determine the remuneration of Ernst & Young Ireland, in its capacity as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 23 funds |
Split 9 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board to issue Class A Ordinary Shares under Irish Law. Capital Structure |
Board | For | FOR 23 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Authorize the Board to opt-out of statutory pre-emption rights under Irish Law. Capital Structure |
Board | For | FOR 23 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Election of Directors: Adriana Karaboutis Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Byron O. Spruell Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Cheryl A. Francis Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gloria Santona Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gregory C. Case Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: James G. Stavridis Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jeffrey C. Campbell Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jin-Yong Cai Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jo Ann Jenkins Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jose Antonio Alvarez Director Elections |
Board | For | FOR 23 funds |
Split 3 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Lester B. Knight Director Elections |
Board | For | FOR 23 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Richard C. Notebaert Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Sarah E. Smith Director Elections |
Board | For | FOR 23 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 23 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Re-appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 23 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | Split 25 FOR, 3 AGAINST |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Approval of an amendment to APA's 2016 Omnibus Compensation Plan to extend its term and increase the shares authorized for issuance thereunder Compensation |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Annell R. Bay Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Anya Weaving Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Chansoo Joung Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Charles W. Hooper Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: David L. Stover Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: H. Lamar McKay Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: John J. Christmann IV Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Juliet S. Ellis Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Kenneth M. Fisher Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Peter A. Ragauss Director Elections |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Ratification of appointment of Ernst & Young LLP as APA's independent auditor Audit-related |
Board | For | FOR 20 funds |
Split 5 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
Split 9 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 12 funds |
Split 9 FOR, 2 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
Split 6 FOR, 3 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 6 FOR, 3 ABSTAIN |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | The ratification of the appointment of Deloitte & Touche LLP as AGM's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 17 funds |
Split 4 FOR, 1 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
Split 3 FOR, 2 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 2 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Approval on an advisory basis of executive compensation paid by the Company. Say-on-Pay |
Board | For | FOR 14 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2026. Audit-related |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLE INC. | February 24, 2026 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 68 funds |
Split 11 FOR, 1 AGAINST, 8 ABSTAIN |
| APPLE INC. | February 24, 2026 | Ratification of the appointment of Ernst & Young LLP as Apple's independent registered public accounting firm for fiscal 2026 Audit-related |
Board | For | FOR 55 funds |
Split 12 FOR, 8 ABSTAIN |
| APPLE INC. | February 24, 2026 | The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Wanda Austin Director Elections |
Board | For | FOR 55 funds |
Split 10 FOR, 8 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve an amendment to the Company's Second Amended and Restated Articles of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 200,000,000 shares. Capital Structure |
Board | For | FOR 3 funds |
Split 2 FOR, 1 AGAINST |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve the Company's 2024 Equity Compensation Plan amendment to increase the number of shares of common stock authorized for issuance by 15,000,000 shares. Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
Split 2 AGAINST, 1 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Ratify the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending May 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Joe A. Raver Director Elections |
Board | For | Split 1 FOR, 16 WITHHOLD |
Split 5 FOR, 6 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | FOR 17 funds |
Split 3 FOR, 8 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Richard J. Simoncic Director Elections |
Board | For | FOR 17 funds |
Split 5 FOR, 6 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Ratification of the Audit Committee's appointment of independent auditors. Audit-related |
Board | For | FOR 17 funds |
Split 6 FOR, 5 ABSTAIN |
| APPLIED MATERIALS, INC. | March 12, 2026 | Ratification of the appointment of KPMG LLP as Applied Materials' independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 32 funds |
Split 5 FOR, 1 AGAINST, 2 ABSTAIN |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 52 funds |
Split 4 FOR, 4 AGAINST, 3 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 39 funds |
Split 8 FOR, 3 ABSTAIN |
← Previous Page 5 of 105 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.